American Family Physician. 2026;114(2):173-174.
In patients with MASLD, excess adiposity leads to metabo-inflammation, metabolic dysfunction, and end-organ liver diseases, thus obesity-oriented treatment while monitoring liver status may be a holistic approach to care.
Copyright © 2026 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.
